+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Uveitis Market and Competitive Landscape - 2020

  • ID: 5023597
  • Report
  • April 2020
  • Region: Europe
  • Fore Pharma
1 of 2
The research report Europe Uveitis Market and Competitive Landscape - 2020, provides comprehensive insights into the Uveitis pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecasts the Uveitis market size and drug sales. It also provides insights into Uveitis epidemiology and late stage pipeline.

This research covers the following: Uveitis treatment options, Uveitis late stage clinical trials pipeline, Uveitis prevalence by countries, Uveitis market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries Germany, France, Italy, Spain, UK, Europe (EU5 Countries).

Research Scope:
  • Countries: Germany, France, Italy, Spain, UK, Europe
  • Uveitis pipeline: Find out drugs in clinical trials for the treatment of Uveitis by development phase 3, phase 2, and phase 1, by pharmacological class and company
  • Uveitis epidemiology: Find out the number of patients diagnosed (prevalence) with Uveitis by countries
  • Uveitis drugs: Identify key drugs marketed and prescribed for Uveitis in the US, including trade name, molecule name, and company
  • Uveitis drugs sales: Find out the sales value for Uveitis drugs by countries
  • Uveitis market valuations: Find out the market size for Uveitis drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2024
  • Uveitis drugs market share: Find out the market shares for key drugs by countries
Benefits of this Research:
  • Evaluate commercial market opportunities for Uveitis drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in the Uveitis market
  • Develop in-depth knowledge of competition and markets
  • Analyze Uveitis drug sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track Market Events and Trends and analyze key events in the Uveitis market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies

This report will be delivered within 2 business days.
Note: Product cover images may vary from those shown
2 of 2
1. Uveitis Treatment Options

2. Uveitis Pipeline Insights
2.1. Uveitis Phase 3 Clinical Trials
2.2. Uveitis Phase 2 Clinical Trials
2.3. Uveitis Phase 1 Clinical Trials

3. Uveitis Epidemiology Analysis by Countries

4. Germany Uveitis Market Insights
4.1. Marketed Drugs for Uveitis in Germany
4.2. Germany Uveitis Market Size & Forecast
4.3. Germany Uveitis Drugs Sales Forecast
4.4. Germany Uveitis Market Share Analysis

5. France Uveitis Market Insights
5.1. Marketed Drugs for Uveitis in France
5.2. France Uveitis Market Size & Forecast
5.3. France Uveitis Product Sales Forecast
5.4. France Uveitis Market Share Analysis

6. Italy Uveitis Market Insights
6.1. Marketed Drugs for Uveitis in Italy
6.2. Italy Uveitis Market Size & Forecast
6.3. Italy Uveitis Product Sales Forecast
6.4. Italy Uveitis Market Share Analysis

7. Spain Uveitis Market Insights
7.1. Marketed Drugs for Uveitis in Spain
7.2. Spain Uveitis Market Size & Forecast
7.3. Spain Uveitis Product Sales Forecast
7.4. Spain Uveitis Market Share Analysis

8. UK Uveitis Market Insights
8.1. Marketed Drugs for Uveitis in UK
8.2. UK Uveitis Market Size & Forecast
8.3. UK Uveitis Product Sales Forecast
8.4. UK Uveitis Market Share Analysis

9. Europe Uveitis Market Insights
9.1. Europe Uveitis Market Size & Forecast
9.2. Europe Uveitis Product Sales Forecast
9.3. Europe Uveitis Market Share Analysis

10. Research Methodology

List of Tables
Table 1: Uveitis Phase 3 Clinical Trials, Global, 2020
Table 2: Uveitis Phase 2 Clinical Trials, Global, 2020
Table 3: Uveitis Phase 1 Clinical Trials, Global, 2020
Table 4: Uveitis Prevalence by Countries, 2016 - 2024
Table 5: Marketed Drugs for Uveitis in Germany, 2019
Table 6: Germany Uveitis Market Size & Forecast ($mn), 2016 - 2024
Table 7: Germany Uveitis Product Sales ($mn), 2016 - 2024
Table 8: Germany Uveitis Market Events and Trends, 2016 - 2024
Table 9: Marketed Drugs for Uveitis in France, 2019
Table 10: France Uveitis Market Size & Forecast ($mn), 2016 - 2024
Table 11: France Uveitis Product Sales ($mn), 2016 - 2024
Table 12: France Uveitis Market Events and Trends, 2016 - 2024
Table 13: Marketed Drugs for Uveitis in Italy, 2019
Table 14: Italy Uveitis Market Size & Forecast ($mn), 2016 - 2024
Table 15: Italy Uveitis Product Sales ($mn), 2016 - 2024
Table 16: Italy Uveitis Market Events and Trends, 2016 - 2024
Table 17: Marketed Drugs for Uveitis in Spain, 2019
Table 18: Spain Uveitis Market Size & Forecast ($mn), 2016 - 2024
Table 19: Spain Uveitis Product Sales ($mn), 2016 - 2024
Table 20: Spain Uveitis Market Events and Trends, 2016 - 2024
Table 21: Marketed Drugs for Uveitis in UK, 2019
Table 22: UK Uveitis Market Size & Forecast ($mn), 2016 - 2024
Table 23: UK Uveitis Product Sales ($mn), 2016 - 2024
Table 24: UK Uveitis Market Events and Trends, 2016 - 2024
Table 25: Europe Uveitis Market Size & Forecast ($mn), 2016 - 2024
Table 26: Europe Uveitis Product Sales ($mn), 2016 - 2024

List of Figures
Figure 1: Uveitis Pipeline by Phase (%), Global, 2020
Figure 2: Uveitis Prevalence by Countries, 2016 - 2024
Figure 3: Germany Uveitis Market Size ($mn), 2016 - 2024
Figure 4: Germany Uveitis Product Sales ($mn), 2016 - 2024
Figure 5: Germany Uveitis Market Share by Drugs (%), 2019
Figure 6: Germany Uveitis Market - Future Market Share (%), 2024
Figure 7: France Uveitis Market Size ($mn), 2016 - 2024
Figure 8: France Uveitis Product Sales ($mn), 2016 - 2024
Figure 9: France Uveitis Market Share by Drugs (%), 2019
Figure 10: France Uveitis Market - Future Market Share (%), 2024
Figure 11: Italy Uveitis Market Size ($mn), 2016 - 2024
Figure 12: Italy Uveitis Product Sales ($mn), 2016 - 2024
Figure 13: Italy Uveitis Market Share by Drugs (%), 2019
Figure 14: Italy Uveitis Market - Future Market Share (%), 2024
Figure 15: Spain Uveitis Market Size ($mn), 2016 - 2024
Figure 16: Spain Uveitis Product Sales ($mn), 2016 - 2024
Figure 17: Spain Uveitis Market Share by Drugs (%), 2019
Figure 18: Spain Uveitis Market - Future Market Share (%), 2024
Figure 19: UK Uveitis Market Size ($mn), 2016 - 2024
Figure 20: UK Uveitis Product Sales ($mn), 2016 - 2024
Figure 21: UK Uveitis Market Share by Drugs (%), 2019
Figure 22: UK Uveitis Market - Future Market Share (%), 2024
Figure 23: Europe Uveitis Market Size ($mn), 2016 - 2024
Figure 24: Europe Uveitis Product Sales ($mn), 2016 - 2024
Figure 25: Europe Uveitis Market Share by Drugs (%), 2019
Figure 26: Europe Uveitis Market - Future Market Share (%), 2024
Note: Product cover images may vary from those shown
Adroll
adroll